AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity
AZD8055 是一种强效、选择性、口服生物利用度高的 ATP 竞争性哺乳动物雷帕霉素激酶抑制剂，具有体外和体内抗肿瘤活性
期刊:Cancer Research
影响因子:12.5
doi:10.1158/0008-5472.CAN-09-1751
Christine M Chresta, Barry R Davies, Ian Hickson, Tom Harding, Sabina Cosulich, Susan E Critchlow, John P Vincent, Rebecca Ellston, Darren Jones, Patrizia Sini, Dominic James, Zoe Howard, Phillippa Dudley, Gareth Hughes, Lisa Smith, Sharon Maguire, Marc Hummersone, Karine Malagu, Keith Menear, Richa
